Navigation Links
Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
Date:11/6/2008

e risk that the sale of the company's pulmonary business assets to Novartis Pharmaceuticals Corporation may not close or the closing may be delayed, (v) the company's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or intellectual property licenses from third parties may be required in the future; and (vi) the outcome of any existing or future intellectual property or other litigation related to the company's proprietary product candidates or complex commercial agreements. Other important risks and uncertainties are detailed in the company's reports and other filings with the Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

Stephan Herrera, 415-488-7699

sherrera@nektar.com

Jennifer Ruddock, 650-631-4954

jruddock@nektar.com

NEKTAR THERAPEUTICS

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share information)

Unaudited Unaudited

Three-Months Ended Nine-Months Ended

September 30, September 30,

2008 2007 2008 2007

Revenue:

Product sales and royalties $9,474 $37,497 $28,855 $159,818

Contract research 11,965 18,824 32,977 47,436

Total revenue 21,439 56,321 61,832 207,254

Ope
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Announces Second Quarter 2008 Results
3. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
4. Nektar Therapeutics Announces First Quarter 2008 Results
5. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
6. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
7. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
10. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
11. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 28, 2015 , ... Popular review site Top5MillionaireDatingSites.com recently published ... . According to the listings, MillionaireMatch.com bags the top spot while ... spokesperson of Top5MillionaireDatingSites.com said, “This website has been designed to assist ...
(Date:8/28/2015)... Livermore, CA (PRWEB) , ... August 28, 2015 , ... ... annual Inc. 5000 list, an exclusive ranking of the nation’s fastest-growing private companies. The ... list’s history. With sales growth of 85% over the last three years, PREVENT ranks ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... through health promotion and disease prevention, improving a patient’s quality of life through ... the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and others. A Women’s, ...
(Date:8/27/2015)... , ... August 28, 2015 , ... This new webinar ... that patients are always scheduled for the next visit, their authorizations are in check, ... . , According to Jason Barnes, COO for Genesis Chiropractic Software, growing a practice ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
Breaking Medicine News(10 mins):Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2Health News:Health Clinic Opening and Public Art Unveiling 2Health News:A New Webinar Teaches Chiropractors How to Use Compliance Alerts to Manage Patient Relationships 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4
... ... Collaboration for a New Century (The Collaboration) announced today the availability ... program called savingsdrugcard.com provides a free drug card that will help ... download this card by visiting http://www.SavingsDrugCard.com and can immediately ...
... trouble , TUESDAY, July 7 (HealthDay News) -- Drugs commonly ... heartburn. , A new study in the July issue of ... inhibitor (PPI) actually produced heartburn, acid reflux and indigestion in ... , Although the findings don,t necessarily mean that PPIs don,t ...
... KAMPALA, Uganda and NAIROBI, Kenya and DELHI, India, July 7 ... the International Treatment Preparedness Coalition (ITPC) calls on leaders of ... ensure that AIDS treatment and prevention programs for millions of ... the economic down-turn. , , "Cutting funds for ...
... 2009 Dr. Nima Sharifi, assistant professor of internal medicine ... Medical Institute Early Career Physician-Scientist Award. He is one ... institute to be part of the program, which is aimed ... discoveries into improved treatment for patients. Established in 2006, the ...
... LONDON, July 7 IBM (NYSE: IBM ) ... technical expertise in innovative ways to address the greatest societal challenges ... Awards for Excellence yesterday. , , (Logo: ... the award for World Community Grid , in ...
... ... Ky. and a 22-year veteran of Quorum Health Resources (QHR), the nation,s largest hospital management ... , ... 7, 2009 -- Terry Peeples, CEO of Jennie Stuart Medical Center in Hopkinsville, ...
Cached Medicine News:Health News:Popular Prescription Drug Discount Card Now Available in Arizona Online 2Health News:Popular Prescription Drug Discount Card Now Available in Arizona Online 3Health News:Heartburn Drugs May Contribute to the Problem 2Health News:Heartburn Drugs May Contribute to the Problem 3Health News:World Financial Crisis and AIDS Backlash Threaten Lives 2Health News:World Financial Crisis and AIDS Backlash Threaten Lives 3Health News:UT Southwestern researcher named HHMI Early Career Physician-Scientist 2Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 2Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 3Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 4Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 5Health News:QHR Associate Named Chair of Kentucky Hospital Association Board of Trustees 2
(Date:8/28/2015)... South Korea , Aug. 28, 2015 ... National University and Dr. Ra from Biostar , ... , Confirmed 30% increase of lifespan through multiple IV ... function, physical vitality, and life expectancy found , ... in Korea have determined the possibility that adult mesenchymal ...
(Date:8/28/2015)... LONDON , August 28, 2015 ... approach seamlessly connects people, technologies and care protoc ... improving outcomes and the cost of healthcare delivery   ... PHIA) today announced its presence at  ESC Congress 2015 , where ... Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that connect people ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... JUPITER, Fla., March 7, 2011 Dyadic International, Inc. ... that it will release financial results for the year ... before market open to be followed by a conference ... http://photos.prnewswire.com/prnh/20091214/DYADICLOGO) The conference call may be accessed ...
... Boston Scientific Corporation (NYSE: BSX ) ... its OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System, ... Boston Scientific,s unique platinum chromium (PtCr) alloy designed ... provide interventional cardiologists with a bare-metal stent with ...
Cached Medicine Technology:Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 2Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 3Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 4
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
... Tm Bioscience introduces the Tag-It™ Cystic ... for cystic fibrosis genotyping. With validated performance ... assay will provide superior mutation coverage for ... aid to diagnosis in newborns. ,The ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: